The Technical Analyst
Select Language :
IO Biotech, Inc. [IOBT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

IO Biotech, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

IO Biotech, Inc. is listed at the  Exchange

-1.14% $1.730

America/New_York / 28 mar 2024 @ 16:00


IO Biotech, Inc.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 113.97 mill
EPS: -1.980
P/E: -0.870
Earnings Date: May 13, 2024
SharesOutstanding: 65.88 mill
Avg Daily Volume: 0.143 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.870 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.15x
Company: PE -0.870 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$3.23
(86.79%) $1.501
Date: 2024-03-28
Expected Trading Range (DAY)

$ 1.580 - 1.880

( +/- 8.67%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-15 Zocca Mai-britt Buy 750 000 Stock Option (Right to Buy)
2024-03-15 Sullivan Amy Buy 280 000 Stock Option (Right to Buy)
2024-03-15 Smith Devin Whittemore Buy 185 000 Stock Option (Right to Buy)
2024-03-15 Burkavage Brian Buy 50 000 Stock Option (Right to Buy)
2024-03-15 Ahmad Qasim Iftikhar Buy 280 000 Stock Option (Right to Buy)
INSIDER POWER
96.17
Last 87 transactions
Buy: 67 695 200 | Sell: 7 604 578

Forecast: 16:00 - $1.730

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $1.730
Forecast 2: 16:00 - $1.730
Forecast 3: 16:00 - $1.730
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.730 (-1.14% )
Volume 0.0535 mill
Avg. Vol. 0.143 mill
% of Avg. Vol 37.29 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for IO Biotech, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for IO Biotech, Inc.

RSI

Intraday RSI14 chart for IO Biotech, Inc.

Last 10 Buy & Sell Signals For IOBT

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            IO Biotech, Inc.

IOBT

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 2 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.

Last 10 Buy Signals

Date Signal @
XAUTUSDMar 28 - 20:02$2 229.60
SBDUSDMar 28 - 20:02$4.77
GTCUSDMar 28 - 20:032.15
ETHWUSDMar 28 - 20:034.34
SEIUSDMar 28 - 20:020.862
STORJUSDMar 28 - 20:02$0.829
GALAUSDMar 28 - 20:02$0.0676
KNCUSDMar 28 - 20:02$0.911
API3USDMar 28 - 20:023.83
WANETHUSDMar 28 - 20:003 539.87

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.